Login to Your Account

Other News To Note

Thursday, December 30, 2010
• Endo Pharmaceuticals Inc., of Chadds Ford, Pa., received FDA approval of Fortesta (testosterone 2 percent gel) for low testosterone. Endo licensed the drug, which received an approvable letter in 2009, from Prostrakan Group plc. (See BioWorld Today, Aug. 27, 2009.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription